Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qing Yi Dao Xie Tang
- Development stage
- Preclinical
- Lead developer
- Changsha Hospital of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Qing Yi Dao Xie Tang (also known as Qingyi Daoxie decoction) is a traditional Chinese medicine (TCM) herbal formula developed by Changsha Hospital of Traditional Chinese Medicine (Changsha Eighth Hospital) for the treatment of acute pancreatitis, particularly mild acute pancreatitis classified as Fu Shi Re Jie syndrome. The decoction is administered orally and is designed to clear heat, promote bowel movements (purge/drain), and relieve abdominal distension and pain. It is often evaluated in combination with topical therapies such as Huang Xiao Plaster.
- Other names
- Qing Yi Dao Xie decoctionQingyi Daoxie decoction清胰导泄汤清胰导泻汤
Beyond the preview
Go deeper on Qing Yi Dao Xie Tang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qing Yi Dao Xie Tang.